KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • Pacific Biosciences Of California's Cash from Financing Activities rose 8091.13% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 3712.51%. This contributed to the annual value of -$43.0 million for FY2024, which is 13947.71% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Cash from Financing Activities is $1.5 million, which was up 8091.13% from $2.0 million recorded in Q1 2025.
  • In the past 5 years, Pacific Biosciences Of California's Cash from Financing Activities registered a high of $865.7 million during Q1 2021, and its lowest value of -$81.6 million during Q4 2023.
  • Its 5-year average for Cash from Financing Activities is $69.4 million, with a median of $1.4 million in 2021.
  • In the last 5 years, Pacific Biosciences Of California's Cash from Financing Activities soared by 465697.02% in 2021 and then tumbled by 1006361.42% in 2023.
  • Pacific Biosciences Of California's Cash from Financing Activities (Quarter) stood at $1.3 million in 2021, then tumbled by 38.14% to $819000.0 in 2022, then crashed by 10063.61% to -$81.6 million in 2023, then surged by 38.48% to -$50.2 million in 2024, then soared by 102.93% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $2.0 million for Q1 2025, and -$50.2 million during Q4 2024.